相关实验视频
Updated: Sep 19, 2025

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
在COPD患者和对照患者的支气管活检中,炎症细胞和重塑
Tomas M Eagan1,2, Rune Nielsen1,2, Ingvild Haaland1
1Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.
炎症和呼吸道重塑在COPD不同于健康的吸烟者. 在支气管活检中,巨细胞,氨基细胞和血管变化区分了COPD患者,无论疾病的严重程度如何.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 呼吸道病理 呼吸道病理
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,炎症和气道重塑的机制在不同疾病严重程度方面尚未完全理解.
- 了解这些过程对于开发有针对性的疗法至关重要.
研究的目的:
- 与健康对照人群相比,研究COPD患者支气管壁的细胞和结构变化.
- 探索炎症和重塑如何随着COPD的严重程度和吸烟状态而变化.
主要方法:
- 在47名COPD患者和35名健康对照人群中进行了支气管支气管洗 (BAL) 支气管镜检查和内支气管活检.
- 免疫组织化学和特定染色物被用来量化炎症细胞 (巨细胞,乙氨基基细胞,淋巴细胞),内皮细胞,光滑肌动蛋白,粘液细胞和网状底膜.
主要成果:
- 与健康个体相比,COPD患者表现出巨细胞,乙氨基和粘膜下血管的增加.
- 健康吸烟者的淋巴细胞比从不吸烟的人少.
- 与GOLD I/II阶段的COPD患者相比,GOLD III/IV阶段的COPD患者表现出更高的乙素细胞数量和更大的光滑肌肉面积.
结论:
- 吸烟会影响健康个体的炎症.
- 支气管活检中显著的巨细胞,乙氨基细胞和血管性模式可以区分COPD和非COPD.
- 这些发现突出了COPD气道的特定病理特征,这些特征可能作为治疗点.
更多相关视频
07:03Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
Published on: May 4, 2017
11:02Human Lung Dendritic Cells: Spatial Distribution and Phenotypic Identification in Endobronchial Biopsies Using Immunohistochemistry and Flow Cytometry
Published on: January 20, 2017
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...